These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6766799)
1. Treatment of cultured human colon carcinoma cells with fluorinated pyrimidines. Drewinko B; Yang LY; Ho DH; Benvenuto J; Loo TL; Freireich EJ Cancer; 1980 Mar; 45(5 Suppl):1144-58. PubMed ID: 6766799 [TBL] [Abstract][Full Text] [Related]
2. Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT 29 colorectal carcinoma cells. Link KH; Aigner KR; Peschau K; Warthona M; Schwemmle K; Danenberg PV Cancer Chemother Pharmacol; 1988; 22(1):58-62. PubMed ID: 2969305 [TBL] [Abstract][Full Text] [Related]
3. Irreversible cytotoxic effect of a novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21. Mori H; Nakayama K; Ishida R; Ito S; Nagai H; Koda A Anticancer Drugs; 1997 Jun; 8(5):482-8. PubMed ID: 9215612 [TBL] [Abstract][Full Text] [Related]
4. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase. van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671 [TBL] [Abstract][Full Text] [Related]
5. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin. Iigo M; Nishikata K; Hoshi A Jpn J Cancer Res; 1992 Apr; 83(4):392-6. PubMed ID: 1387127 [TBL] [Abstract][Full Text] [Related]
6. Combination of 5-fluorouracil and irinotecan on modulation of thymidylate synthase and topoisomerase I expression and cell cycle regulation in human colon cancer LoVo cells: clinical relevance. Xu JM; Azzariti A; Tommasi S; Lacalamita R; Colucci G; Johnston PG; Church SW; Paradiso A Clin Colorectal Cancer; 2002 Nov; 2(3):182-8. PubMed ID: 12482336 [TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients. Casale F; Canaparo R; Serpe L; Muntoni E; Pepa CD; Costa M; Mairone L; Zara GP; Fornari G; Eandi M Pharmacol Res; 2004 Aug; 50(2):173-9. PubMed ID: 15177306 [TBL] [Abstract][Full Text] [Related]
8. Enhanced accumulation of 5-fluorouracil in human tumors in athymic mice by co-administration of Ftorafur and uracil. Tang SG; Hornbeck CL; Byfield JE Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1687-9. PubMed ID: 6434499 [TBL] [Abstract][Full Text] [Related]
9. Cellular basis for the inefficacy of 5-FU in human colon carcinoma. Drewinko B; Yang LY Cancer Treat Rep; 1985 Dec; 69(12):1391-8. PubMed ID: 4075316 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors. Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450 [TBL] [Abstract][Full Text] [Related]
11. Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes. Peters GJ; Braakhuis BJ; de Bruijn EA; Laurensse EJ; van Walsum M; Pinedo HM Br J Cancer; 1989 Mar; 59(3):327-34. PubMed ID: 2522792 [TBL] [Abstract][Full Text] [Related]
12. Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78. Yun S; Han YS; Lee JH; Kim S; Lee SH Anticancer Res; 2017 Jun; 37(6):2975-2984. PubMed ID: 28551635 [TBL] [Abstract][Full Text] [Related]
13. Effects of 5-fluorodeoxyuridine and related halogenated pyrimidines on the sand-dollar embryo. KARNOFSKY DA; BASCH RS J Biophys Biochem Cytol; 1960 Feb; 7(1):61-71. PubMed ID: 14404541 [TBL] [Abstract][Full Text] [Related]
14. Recombinant human interferon alpha-2a increases 5-fluorouracil efficacy by elevating fluorouridine concentration in tumor tissue. Kase S; Kubota T; Watanabe M; Teramoto T; Kitajima M; Hoffman RM Anticancer Res; 1994; 14(3A):1155-9. PubMed ID: 8074466 [TBL] [Abstract][Full Text] [Related]
15. Selectivity of action of 5-FU: biochemical basis. Rustum YM; Danhauser L; Wang G Bull Cancer; 1979; 66(1):43-7. PubMed ID: 154352 [TBL] [Abstract][Full Text] [Related]
16. [Mechanism of the chromosome damaging effect of ftorafur]. Volgareva GM; Sokova OI; Pogosiants EE Genetika; 1977; 13(3):461-7. PubMed ID: 142687 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-Fluorouracil or ftorafur and X rays. Byfield JE; Calabro-Jones P; Klisak I; Kulhanian F Int J Radiat Oncol Biol Phys; 1982 Nov; 8(11):1923-33. PubMed ID: 6818194 [TBL] [Abstract][Full Text] [Related]
18. Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignancies. Hidalgo M; Villalona-Calero MA; Eckhardt SG; Drengler RL; Rodriguez G; Hammond LA; Diab SG; Weiss G; Garner AM; Campbell E; Davidson K; Louie A; O'Neil JD; von Borstel R; Von Hoff DD; Rowinsky EK J Clin Oncol; 2000 Jan; 18(1):167-77. PubMed ID: 10623707 [TBL] [Abstract][Full Text] [Related]
19. Radiosensitization of cultured human colon adenocarcinoma cells by 5-fluorouracil: effects on cell survival, DNA repair, and cell recovery. Hughes LL; Luengas J; Rich TA; Murray D Int J Radiat Oncol Biol Phys; 1992; 23(5):983-91. PubMed ID: 1639656 [TBL] [Abstract][Full Text] [Related]
20. Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells. Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Melioli GG; Rosso R; Bertino JR J Natl Cancer Inst; 1993 Dec; 85(23):1937-44. PubMed ID: 8230285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]